Omid Farokhzad - Net Worth and Insider Trading
Omid Farokhzad Net Worth
The estimated net worth of Omid Farokhzad is at least $4 Million dollars as of 2024-11-29. Omid Farokhzad is the CEO AND CHAIR of Seer Inc and owns about 1,436,285 shares of Seer Inc (SEER) stock worth over $4 Million. Omid Farokhzad is also the Director of Cartesian Therapeutics Inc and owns about 2,778 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $49,754. Details can be seen in Omid Farokhzad's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Omid Farokhzad has not made any transactions after 2024-03-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Omid Farokhzad
Omid Farokhzad Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Omid Farokhzad owns 5 companies in total, including Cartesian Therapeutics Inc (RNAC) , DNIB Unwind Inc (BINDQ) , and Seer Inc (SEER) among others .
Click here to see the complete history of Omid Farokhzad’s form 4 insider trades.
Insider Ownership Summary of Omid Farokhzad
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RNAC | Cartesian Therapeutics Inc | 2019-01-25 | director & 10 percent owner |
BINDQ | DNIB Unwind Inc | 2013-09-19 | director |
SEER | Seer Inc | 2024-03-07 | director & 10 percent owner & CEO and Chair of the Board |
2021-05-25 | director | ||
2021-05-25 | director |
Omid Farokhzad Latest Holdings Summary
Omid Farokhzad currently owns a total of 2 stocks. Among these stocks, Omid Farokhzad owns 1,436,285 shares of Seer Inc (SEER) as of March 7, 2024, with a value of $4 Million and a weighting of 98.63%. Omid Farokhzad also owns 2,778 shares of Cartesian Therapeutics Inc (RNAC) as of January 25, 2019, with a value of $49,754 and a weighting of 1.37%.
Latest Holdings of Omid Farokhzad
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SEER | Seer Inc | 2024-03-07 | 1,436,285 | 2.50 | 3,590,713 |
RNAC | Cartesian Therapeutics Inc | 2019-01-25 | 2,778 | 17.91 | 49,754 |
Holding Weightings of Omid Farokhzad
Omid Farokhzad Form 4 Trading Tracker
According to the SEC Form 4 filings, Omid Farokhzad has made a total of 9 transactions in Seer Inc (SEER) over the past 5 years, including 1 buys and 8 sells. The most-recent trade in Seer Inc is the sale of 52,857 shares on March 7, 2024, which brought Omid Farokhzad around $107,300.
According to the SEC Form 4 filings, Omid Farokhzad has made a total of 0 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years. The most-recent trade in Cartesian Therapeutics Inc is the acquisition of 2,778 shares on January 25, 2019, which cost Omid Farokhzad around $125,000.
Insider Trading History of Omid Farokhzad
- 1
Omid Farokhzad Trading Performance
GuruFocus tracks the stock performance after each of Omid Farokhzad's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Omid Farokhzad is -1.36%. GuruFocus also compares Omid Farokhzad's trading performance to market benchmark return within the same time period. The performance of stocks bought by Omid Farokhzad within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Omid Farokhzad's insider trading performs compared to the benchmark.
Performance of Omid Farokhzad
Omid Farokhzad Ownership Network
Omid Farokhzad Owned Company Details
What does Cartesian Therapeutics Inc do?
Who are the key executives at Cartesian Therapeutics Inc?
Omid Farokhzad is the director & 10 percent owner of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include Chief Medical Officer Peter G Traber , director & President & CEO Carsten Brunn , and Chief Scientific Officer Takashi Kei Kishimoto .
Cartesian Therapeutics Inc (RNAC) Insider Trades Summary
Over the past 18 months, Omid Farokhzad made no insider transaction in Cartesian Therapeutics Inc (RNAC). Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,868,993 shares made by Timothy A Springer , a net sale of 52,115 shares made by , and a net purchase of 7,500 shares made by Timothy C Barabe .
In summary, during the past 3 months, insiders sold 228,172 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 637,661 shares, with a net purchase of 409,489 shares. During the past 18 months, 228,293 shares of Cartesian Therapeutics Inc (RNAC) were sold and 693,954 shares were bought by its insiders, resulting in a net purchase of 465,661 shares.
Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cartesian Therapeutics Inc Insider Transactions
Omid Farokhzad Mailing Address
Above is the net worth, insider trading, and ownership report for Omid Farokhzad. You might contact Omid Farokhzad via mailing address: C/o Seer, Inc., 3800 Bridge Parkway, Suite 102, Redwood City Ca 94065.